This drug, developed by Eli Lilly, is expected to be the next step in addressing and treating overweight and obesity
The Role of Soluble Uric Acid in Modulating Autophagy Flux and Inflammasome Activation during Bacterial Infection in Macrophages
Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors
Drugs that mimic the bodys natural GLP-1 hormone have been around since 2005, but tirzepatide was the first to target both GLP-1 and the GIP receptors, which act in synergy with GLP-1 and help stimulate insulin release
Aim for at least -1 cup of fruit or non-starchy vegetables at breakfast
A Lilly spokesperson said the company is completing seven additional trials on retatrutide, which are expected to be completed in 2026